Biolase Net Profit Margin 2010-2023 | BIOL
Biolase net profit margin from 2010 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue.
Biolase Net Profit Margin Historical Data |
Date |
TTM Revenue |
TTM Net Income |
Net Margin |
2023-12-31 |
$0.05B |
$-0.04B |
-79.17% |
2023-09-30 |
$0.05B |
$-0.03B |
-53.06% |
2023-06-30 |
$0.05B |
$-0.03B |
-58.00% |
2023-03-31 |
$0.05B |
$-0.03B |
-62.50% |
2022-12-31 |
$0.05B |
$-0.03B |
-60.42% |
2022-09-30 |
$0.05B |
$-0.02B |
-52.17% |
2022-06-30 |
$0.04B |
$-0.02B |
-43.18% |
2022-03-31 |
$0.04B |
$-0.01B |
-34.15% |
2021-12-31 |
$0.04B |
$-0.02B |
-41.03% |
2021-09-30 |
$0.04B |
$-0.02B |
-47.22% |
2021-06-30 |
$0.03B |
$-0.03B |
-93.94% |
2021-03-31 |
$0.03B |
$-0.04B |
-129.63% |
2020-12-31 |
$0.02B |
$-0.03B |
-141.67% |
2020-09-30 |
$0.03B |
$-0.03B |
-128.00% |
2020-06-30 |
$0.03B |
$-0.02B |
-74.07% |
2020-03-31 |
$0.03B |
$-0.02B |
-57.58% |
2019-12-31 |
$0.04B |
$-0.02B |
-47.37% |
2019-09-30 |
$0.04B |
$-0.02B |
-51.22% |
2019-06-30 |
$0.04B |
$-0.02B |
-48.84% |
2019-03-31 |
$0.05B |
$-0.02B |
-47.83% |
2018-12-31 |
$0.05B |
$-0.02B |
-47.83% |
2018-09-30 |
$0.05B |
$-0.02B |
-50.00% |
2018-06-30 |
$0.05B |
$-0.02B |
-50.00% |
2018-03-31 |
$0.05B |
$-0.02B |
-46.81% |
2017-12-31 |
$0.05B |
$-0.02B |
-43.75% |
2017-09-30 |
$0.05B |
$-0.02B |
-40.82% |
2017-06-30 |
$0.05B |
$-0.02B |
-35.29% |
2017-03-31 |
$0.05B |
$-0.02B |
-34.62% |
2016-12-31 |
$0.05B |
$-0.02B |
-34.62% |
2016-09-30 |
$0.05B |
$-0.01B |
-24.53% |
2016-06-30 |
$0.05B |
$-0.02B |
-29.41% |
2016-03-31 |
$0.05B |
$-0.02B |
-36.73% |
2015-12-31 |
$0.05B |
$-0.02B |
-38.78% |
2015-09-30 |
$0.05B |
$-0.02B |
-44.68% |
2015-06-30 |
$0.05B |
$-0.02B |
-38.78% |
2015-03-31 |
$0.05B |
$-0.02B |
-38.30% |
2014-12-31 |
$0.05B |
$-0.02B |
-37.50% |
2014-09-30 |
$0.05B |
$-0.02B |
-32.00% |
2014-06-30 |
$0.05B |
$-0.02B |
-34.69% |
2014-03-31 |
$0.05B |
$-0.01B |
-26.42% |
2013-12-31 |
$0.06B |
$-0.01B |
-21.43% |
2013-09-30 |
$0.06B |
$-0.01B |
-15.00% |
2013-06-30 |
$0.06B |
$-0.01B |
-9.68% |
2013-03-31 |
$0.06B |
$-0.01B |
-8.33% |
2012-12-31 |
$0.06B |
$-0.00B |
-7.02% |
2012-09-30 |
$0.05B |
$-0.01B |
-13.73% |
2012-06-30 |
$0.05B |
$-0.01B |
-14.00% |
2012-03-31 |
$0.05B |
$-0.01B |
-12.00% |
2011-12-31 |
$0.05B |
$-0.01B |
-10.20% |
2011-09-30 |
$0.05B |
$-0.00B |
-6.52% |
2011-06-30 |
$0.04B |
$-0.01B |
-12.82% |
2011-03-31 |
$0.03B |
$-0.01B |
-24.24% |
2010-12-31 |
$0.03B |
$-0.01B |
-46.15% |
2010-09-30 |
$0.03B |
$-0.01B |
-50.00% |
2010-06-30 |
$0.03B |
$-0.01B |
-28.13% |
2010-03-31 |
$0.04B |
$-0.00B |
-7.50% |
2009-12-31 |
$0.04B |
$-0.00B |
-6.98% |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical & Dental Supplies |
$0.005B |
$0.049B |
Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.
|